Literature DB >> 10673324

Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells.

M Salinas1, R López-Valdaliso, D Martín, A Alvarez, A Cuadrado.   

Abstract

Accumulation of ceramide has been reported in stress- and receptor-induced apoptosis in the nervous system. However, its role in apoptosis signaling remains elusive. We describe here the inhibition of the NGF-activated phosphoinositide 3-kinase (PI3K)-PKB/Akt1 survival pathway by the cell permeable analog C2-ceramide. C2-ceramide did not inhibit ERK, PI3K, or PDK1 activities and did not alter the translocation of PDK1 and Akt1 to the plasma membrane, but blocked nuclear translocation of Akt1. Down-regulation of the Akt pathway was due to enhanced dephosphorylation of Akt1 at residues T308 and S473. Moreover, Akt1 was dephosphorylated in vitro by a cation-independent phosphatase involving ceramide-activated protein phosphatase (CAPP). Membrane-anchored Akt1 was more resistant to dephosphorylation/inactivation by C2-ceramide than wild-type Akt1. Consistently, N-myristylated-Akt1 conferred resistance to the apoptosis induced by C2-ceramide in PC12 cells. These results provide a novel mechanism for induction of apoptosis by ceramide in nerve-derived cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673324     DOI: 10.1006/mcne.1999.0813

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  53 in total

1.  An SH2-domain-containing kinase negatively regulates the phosphatidylinositol-3 kinase pathway.

Authors:  J Moniakis; S Funamoto; M Fukuzawa; J Meisenhelder; T Araki; T Abe; R Meili; T Hunter; J Williams; R A Firtel
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

Review 2.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

Review 3.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 4.  Ceramide: second messenger or modulator of membrane structure and dynamics?

Authors:  Wim J van Blitterswijk; Arnold H van der Luit; Robert Jan Veldman; Marcel Verheij; Jannie Borst
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

Review 5.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 6.  Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.

Authors:  Arundhati Jana; Edward L Hogan; Kalipada Pahan
Journal:  J Neurol Sci       Date:  2009-01-14       Impact factor: 3.181

Review 7.  Defect of insulin signal in peripheral tissues: Important role of ceramide.

Authors:  Rima Hage Hassan; Olivier Bourron; Eric Hajduch
Journal:  World J Diabetes       Date:  2014-06-15

8.  Natural sphingadienes inhibit Akt-dependent signaling and prevent intestinal tumorigenesis.

Authors:  Henrik Fyrst; Babak Oskouian; Padmavathi Bandhuvula; Yaqiong Gong; Hoe Sup Byun; Robert Bittman; Andrew R Lee; Julie D Saba
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

9.  Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells.

Authors:  Darren J Powell; Sophie Turban; Alexander Gray; Eric Hajduch; Harinder S Hundal
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

10.  Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism.

Authors:  Darren J Powell; Eric Hajduch; Gursant Kular; Harinder S Hundal
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.